ALC Alcon Inc.

NYSE
$74.25

Alcon Inc. (ALC) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is $0.90 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -1.6% since its last earnings release on August 10, 2026.

Alcon Beat Consensus Estimates, Raises Earnings Guidance to be In-line with Estimates
Monday, August 10, 2026 · 4:30 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:30 PM ET
Earnings Whisper
-
vs $0.90
Rev est $2.76B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $74.37

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Alcon Inc.

Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.

Sector

Healthcare

Industry

Medical Appliances/Equipment